Suono Bio is developing therapeutic products for inflammatory-mediated diseases leveraging their ultra-rapid and formulation independent delivery technology. Suono Bio’s platform enables rapid, localized delivery of small molecules, biologics, and nucleic acids and gene therapies without the need for encapsulation of the therapeutic. For more information, please visit www.suonobio.com
Location: United States, Massachusetts, Cambridge
Employees: 11-50
Total raised: $8.5M
Founded date: 2017
Investors 2
| Date | Name | Website |
| - | Medical Te... | medtechvp.... |
| - | Engine Ven... | enginevent... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 13.07.2021 | Series A | $8.5M | - |
Mentions in press and media 2
| Date | Title | Description |
| 13.07.2021 | Suono Bio Raises $8.5M in Series A Funding | Suono Bio, Inc., a Foxborough, Mass.-based advancing treatments of gastrointestinal diseases, raised an $8.5m Series A financing. The round was led by Axil Capital and Mizuho Securities Principal Investment, with participation from Taiwania... |
| 19.09.2017 | MIT’s The Engine, Now With $200M, Makes First Bets: 3 Takeaways | Share Share on Facebook Share on Twitter LinkedIn Email Reprints [Updated 9/20/17, 8:18 am. See below.] Now the real work begins for The Engine, MIT’s ambitious venture fund and incubator. The organization announced its first batch of seven... |